Gluteal tendinitis

M13_GLUTEALTEND

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M76.0 Cause of death: ICD-10 — M76.0 2 out of 7 registries used, show all original rules.	2020
4. Check minimum number of events None	2020
5. Include endpoints None	2020
6. Filter based on genotype QC (FinnGen only)	1841

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M76
Name in latin: Tendinitis musculi glutei

NAME	M13_GLUTEALTEND
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M760
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M760
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Gluteal tendinitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	5539	4224	1289
Only index persons	5456	4184	1272
Unadjusted period prevalence (%)
Whole population	0.10	0.12	0.04
Only index persons	0.13	0.15	0.05
Median age at first event (years)
Whole population	56.69	56.80	56.55
Only index persons	56.71	56.76	56.52

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1841	1490	351
Unadjusted period prevalence (%)	0.46	0.53	0.16
Median age at first event (years)	61.12	59.97	66.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1898: Matched controls
18980

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L13

ICPC

Hip symptom/complaint

7.2

307.7

936

2262

N03AX12

ATC

[U] gabapentin; oral

8.1

307.7

554

917

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

111.8

307.7

218

M70.6

ICD-10 Finland

Trochanteric bursitis

10.2

307.7

836

1359

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

34.3

307.7

439

165

M48.0

ICD-10 Finland

Spinal stenosis

67.6

307.7

414

M76.0

ICD-10 Finland

Gluteal tendinitis

+∞

307.7

1898

116

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

33.9

307.7

341

122

M54.5

ICD-10 Finland

Low back pain

6.0

307.7

1056

3303

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

39.5

307.7

525

182

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

43.6

307.7

489

150

M54.4

ICD-10 Finland

Lumbago with sciatica

10.1

307.7

663

957

N03AX16

ATC

[U] pregabalin

6.5

307.7

729

1654

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

117.9

298.5

152

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

10.6

261.9

311

345

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

22.1

237.6

179

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

34.8

236.8

151

M47.82

ICD-10 Finland

Other spondylosis, cervical region

29.4

233.2

157

L03

ICPC

Low back symptom/complaint

4.6

230.0

863

2918

N02AX02

ATC

tramadol; systemic, rectal

4.4

224.0

1096

4484

N02BF01

ATC

gabapentin; oral

7.0

221.8

387

672

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.7

217.6

399

728

M25.5

ICD-10 Finland

Pain in joint

4.2

209.0

1046

4293

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

19.3

207.5

166

M79.6

ICD-10 Finland

Pain in limb

4.3

206.7

1256

5891

M47.9

ICD-10 Finland

Spondylosis, unspecified

58.8

206.6

116

N06AX21

ATC

duloxetine; oral

5.9

199.1

420

873

M54.1

ICD-10 Finland

Radiculopathy

20.9

196.7

151

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

27.5

183.4

126

M01AH05

ATC

etoricoxib; oral

5.4

183.2

1589

9282

N02AJ06

ATC

codeine and paracetamol; systemic

3.9

181.1

1129

5236

NF1AA

NOMESCO Finland

Hip X-ray examination

5.8

172.9

360

734

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.8

165.5

756

2823

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.9

165.2

338

677

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

76.9

163.9

M54.3

ICD-10 Finland

Sciatica

9.9

156.8

188

208

M16.1

ICD-10 Finland

Other primary coxarthrosis

4.7

154.6

424

1089

M43.1

ICD-10 Finland

Spondylolisthesis

25.1

153.7

109

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

14.8

147.1

134

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.3

140.2

1060

5284

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

34.5

139.9

M03BX02

ATC

tizanidine; oral

3.7

132.1

1458

8972

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

10.0

123.0

145

156

NE1BG, ,

SPAT

10.3

121.5

140

146

M01AH01

ATC

celecoxib; oral

3.6

120.8

509

1754

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

187.7

118.9

123

A02BC05

ATC

esomeprazole; systemic

3.0

118.0

1017

5302

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

18.8

116.3

N02BF02

ATC

pregabalin; oral

5.9

115.3

225

426

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.0

108.1

703

3112

M03BC01

ATC

orphenadrine (citrate); systemic

3.2

108.0

570

2240

M79.1

ICD-10 Finland

Myalgia

3.5

106.9

456

1572

XA402

NOMESCO Finland

ENMG

12.3

106.5

108

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.1

103.9

333

945

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.8

101.9

879

4489

M79.7

ICD-10 Finland

Fibromyalgia

7.3

98.0

149

218

NA3BG, ,

SPAT

7.0

97.5

154

235

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.7

96.6

243

572

M01AC06

ATC

meloxicam; systemic, rectal

2.7

96.5

885

4629

L86

ICPC

Back syndrome with radiating pain

6.3

94.8

169

292

L28

ICPC

Limited function/disability (L)

3.1

92.3

477

1832

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.7

90.9

226

526

R4110, ,

SPAT

3.3

90.6

420

1511

M01AB05

ATC

diclofenac; systemic, rectal

2.9

90.4

1433

9711

H02AB06

ATC

prednisolone; systemic

2.6

89.7

1064

6240

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

15.3

88.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.5

86.3

227

552

M54.2

ICD-10 Finland

Cervicalgia

4.9

83.1

196

436

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.7

82.5

293

886

M01AH02

ATC

rofecoxib; oral

3.5

82.3

320

1027

M50.3

ICD-10 Finland

Other cervical disc degeneration

20.3

82.0

A02BC02

ATC

pantoprazole; systemic

2.8

79.5

1475

10455

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

13.4

78.8

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.1

77.3

119

176

R52.2

ICD-10 Finland

Other chronic pain

6.7

77.1

127

202

N06AA09

ATC

amitriptyline; systemic

4.0

76.8

242

672

M54.6

ICD-10 Finland

Pain in thoracic spine

4.7

76.8

190

439

M70.7

ICD-10 Finland

Other bursitis of hip

6.8

76.0

123

192

L08

ICPC

Shoulder symptom/complaint

2.6

75.9

592

2794

M01AE02

ATC

naproxen; oral, rectal

2.5

75.4

1233

8128

M54

ICD-10 Finland

Dorsalgia

3.4

74.3

308

1026

A01

ICPC

Pain general/multiple sites

3.6

74.1

273

843

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

28.5

74.1

M76.6

ICD-10 Finland

Achilles tendinitis

5.3

73.9

155

311

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

10.8

73.1

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

10.8

71.3

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

71.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.9

70.7

224

623

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

69.8

581

2812

R51.80

ICD-10 Finland

Headache

2.9

69.7

391

1550

G44.2

ICD-10 Finland

Tension-type headache

3.0

69.6

355

1335

L17

ICPC

Foot/toe symptom/complaint

2.4

69.5

721

3855

NF1AA, ,

SPAT

4.3

68.7

192

487

R52.9

ICD-10 Finland

Pain, unspecified

3.5

68.6

271

874

M01AX17

ATC

nimesulide; oral

2.6

68.1

542

2564

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.7

68.0

450

1944

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

67.8

782

4369

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

4.3

67.6

186

466

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

4.2

67.4

194

503

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.5

67.0

616

3112

M54.8

ICD-10 Finland

Other dorsalgia

5.9

66.8

124

222

NF1DA

NOMESCO Finland

X-ray of hips

8.0

66.7

120

M03BC51

ATC

orphenadrine, combinations; systemic

2.4

66.6

625

3185

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

66.2

645

3340

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

66.0

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

7.4

65.2

135

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.7

65.0

229

684

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

13.7

65.0

J01FA10

ATC

azithromycin; systemic

2.3

64.7

1259

8686

J02AC01

ATC

fluconazole; systemic

2.2

62.7

992

6258

X58

ICD-10 Finland

Exposure to other specified factors

2.9

62.7

357

1421

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

62.2

519

2495

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

61.6

600

3091

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

217.1

61.5

N02BE01

ATC

paracetamol; systemic, rectal

5.1

59.9

1808

15140

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

8.5

59.8

N06AX16

ATC

venlafaxine; oral

2.8

59.3

360

1479

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

306.5

58.6

L01

ICPC

Neck symptom/complaint

2.7

58.6

395

1710

A02BC03

ATC

lansoprazole; oral

2.3

58.1

603

3179

M02AA10

ATC

ketoprofen; topical

2.7

57.9

387

1668

S18

ICPC

Laceration/cut

2.1

56.2

982

6347

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

56.1

510

2533

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

53.6

422

1960

R03AC02

ATC

salbutamol; inhalant

2.1

53.5

1151

7988

M77.1

ICD-10 Finland

Lateral epicondylitis

3.3

53.4

218

713

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.8

53.2

172

483

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.9

53.0

166

456

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

4.3

52.9

145

361

R06.0

ICD-10 Finland

Dyspnoea

2.3

52.7

569

3030

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.7

51.9

313

1275

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.6

50.9

334

1419

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

50.6

600

3309

SPAT1153

SPAT

Removal of sutures

2.2

50.4

644

3655

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.0

50.3

251

923

N06AA10

ATC

nortriptyline; systemic

7.1

50.2

113

M02AA07

ATC

piroxicam; topical

2.1

50.2

745

4475

M01AX05

ATC

glucosamine; oral

2.4

49.8

423

2027

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.9

49.0

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.8

47.7

266

1038

R42

ICD-10 Finland

Dizziness and giddiness

2.2

47.2

485

2513

N06AX11

ATC

mirtazapine; oral

2.1

47.0

715

4310

NE1AA, ,

SPAT

6.2

46.4

136

R01AD09

ATC

mometasone; nasal

2.0

46.1

978

6617

H02AB04

ATC

methylprednisolone; systemic

2.5

45.6

341

1536

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

45.5

392

1883

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

44.9

321

1415

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

44.7

240

916

A02BC01

ATC

omeprazole; systemic

2.1

44.7

536

2945

J01AA02

ATC

doxycycline; systemic

2.4

44.2

1567

12670

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

43.7

845

5505

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

3.7

43.4

146

420

J01DB01

ATC

cefalexin; oral

2.5

43.3

1623

13363

R5599

NOMESCO Finland

Other rehabilitation service

6.0

43.2

132

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

42.5

183

616

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.7

42.4

256

1038

M35.7

ICD-10 Finland

Hypermobility syndrome

10.0

42.0

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

7.6

41.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

41.2

921

6260

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.8

40.7

226

877

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

40.5

1020

7194

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.5

40.1

101

235

L15

ICPC

Knee symptom/complaint

2.0

39.9

571

3329

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.1

39.3

180

628

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

139.6

38.9

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

38.6

397

2039

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.9

38.6

196

724

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

38.6

318

1489

R01AD12

ATC

fluticasone furoate; nasal

1.9

38.5

690

4336

M01AB55

ATC

diclofenac, combinations; oral

3.4

38.4

144

445

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.9

38.3

182

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.8

38.3

194

WX320

NOMESCO Finland

Spinalanesthesy

2.0

38.1

531

3058

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

6.0

38.0

117

L89

ICPC

Osteoarthrosis of hip

3.9

38.0

116

312

UJF32

NOMESCO Finland

Coloscopy

2.0

37.9

517

2953

L29

ICPC

Musculoskeletal sympt/complt other

2.7

37.4

222

890

M76.3

ICD-10 Finland

Iliotibial band syndrome

11.0

37.4

N04BC05

ATC

pramipexole; oral

3.0

37.3

174

613

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.7

37.2

222

892

UKC02

NOMESCO Finland

Cystoscopy

2.5

37.1

273

1214

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.8

37.1

208

810

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

37.0

401

2100

N02AA05

ATC

oxycodone; systemic

2.3

36.9

338

1654

J01MA02

ATC

ciprofloxacin; systemic

1.9

36.9

727

4697

Z01.2

ICD-10 Finland

Dental examination

1.8

36.8

973

6890

P01AB01

ATC

metronidazole; oral, rectal

1.9

36.8

854

5808

L02

ICPC

Back symptom/complaint

2.6

36.8

227

928

N02AJ13

ATC

tramadol and paracetamol; systemic

6.3

36.6

101

R01AD08

ATC

fluticasone; nasal

1.9

36.3

617

3792

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

364.0

36.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

35.9

599

3657

R01AD58

ATC

fluticasone, combinations; nasal

2.0

35.9

552

3279

NFM20

NOMESCO Finland

Excision of bursa of hip or thigh

48.8

35.8

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

48.8

35.8

G04BD12

ATC

mirabegron; oral

2.4

35.7

268

1202

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

35.6

397

2099

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

35.6

919

6438

B01AF01

ATC

rivaroxaban; oral

2.4

34.9

274

1253

Z00.0

ICD-10 Finland

General medical examination

2.1

34.5

392

2084

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

34.5

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.5

34.4

234

1001

R02

ICPC

Shortness of breath/dyspnoea

2.4

34.4

279

1293

M77.4

ICD-10 Finland

Metatarsalgia

2.9

34.4

176

652

R21

ICPC

Throat symptom/complaint

2.0

34.1

431

2384

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

34.0

1032

7552

L16

ICPC

Ankle symptom/complaint

2.4

33.8

273

1263

R06AE07

ATC

cetirizine; oral

1.8

33.7

909

6415

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

6.6

33.3

L14

ICPC

Leg/thigh symptom/complaint

2.7

33.3

195

775

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

9.3

33.1

G54.0

ICD-10 Finland

Brachial plexus disorders

5.9

32.8

102

R05

ICD-10 Finland

Cough

2.0

32.8

465

2675

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

32.5

221

944

M01AE01

ATC

ibuprofen; systemic, rectal

2.9

32.5

1763

15563

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

32.4

243

1087

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

55.3

32.3

R03DC03

ATC

montelukast; oral

2.1

32.2

359

1890

J01FA06

ATC

roxithromycin; oral

1.8

32.2

790

5401

S76.3

ICD-10 Finland

Injury of muscle and tendon of the posterior muscle group at thigh level

5.9

32.0

101

G57.1

ICD-10 Finland

Meralgia paraesthetica

6.0

31.8

J01FA09

ATC

clarithromycin; systemic

1.8

31.6

634

4075

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

31.4

647

4191

M16.3

ICD-10 Finland

Other dysplastic coxarthrosis

9.2

31.3

NA3AA, ,

SPAT

3.7

31.2

101

283

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

11.2

31.2

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

31.0

1095

8279

GD1AA, ,

SPAT

2.1

31.0

369

1989

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.7

31.0

101

284

H02BX01

ATC

methylprednisolone, combinations; systemic

3.4

30.9

114

348

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.4

30.9

114

348

R60.0

ICD-10 Finland

Localized oedema

2.3

30.9

257

1202

L12

ICPC

Hand/finger symptom/complaint

2.1

30.8

366

1971

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

12.1

30.8

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.8

30.5

162

611

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.9

30.4

250

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.7

30.4

278

N05BA04

ATC

oxazepam; oral

1.9

30.4

523

3195

Z01.9

ICD-10 Finland

Special examination, unspecified

2.9

30.3

149

539

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

30.3

156

579

K30

ICD-10 Finland

Functional dyspepsia

2.3

30.3

252

1178

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

30.0

234

1064

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

6.6

29.9

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

29.6

627

4078

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

4.7

29.6

151

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.8

29.2

248

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.8

29.0

156

592

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

29.0

342

1833

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.9

29.0

470

2812

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.9

28.9

145

531

XQ800

NOMESCO Finland

Prick test

2.6

28.8

177

719

AA1AD

NOMESCO Finland

CT of head and brain

1.8

28.6

515

3182

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.7

28.6

1151

8938

G47.3

ICD-10 Finland

Sleep apnoea

1.9

28.4

422

2452

J01DA01

ATC

[U] cefalexin

1.7

28.4

1161

9048

R05

ICPC

Cough

1.8

28.3

507

3127

M01AE52

ATC

naproxen and esomeprazole; oral

3.8

28.3

235

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

28.3

243

1150

WZA90

NOMESCO Finland

Other medical or dental certificate

1.9

28.2

452

2692

R35

ICD-10 Finland

Polyuria

3.0

28.1

128

444

A02BA02

ATC

ranitidine; systemic

2.0

28.0

350

1915

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

27.9

897

6534

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

27.9

1393

11455

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.3

27.9

111

R07.3

ICD-10 Finland

Other chest pain

2.4

27.8

209

933

A29

ICPC

General symptom/complaint other

2.2

27.8

279

1406

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.1

27.8

193

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.2

27.6

253

1229

C05AA08

ATC

fluocortolone; rectal, topical

2.1

27.6

283

1438

M43.0

ICD-10 Finland

Spondylolysis

47.9

27.5

N03AE01

ATC

clonazepam; systemic

3.1

27.4

119

401

M01AH03

ATC

valdecoxib; oral

3.0

27.4

126

439

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

27.3

314

1665

A02BC04

ATC

rabeprazole; oral

2.4

27.3

204

908

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

27.3

441

2629

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.6

27.2

149

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.3

27.2

105

330

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

27.1

J01FF01

ATC

clindamycin; systemic

1.8

27.1

514

3219

SPAT1310

SPAT

Counselling related to known health issue

1.8

27.1

578

3749

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

26.8

432

2570

M76.1

ICD-10 Finland

Psoas tendinitis

76.3

26.8

EB1VA, ,

NOMESCO Finland

1.9

26.8

384

2200

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

6.3

26.7

J01CA04

ATC

amoxicillin; systemic

1.9

26.4

1568

13459

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.5

26.3

271

S83.2

ICD-10 Finland

Tear of meniscus, current

2.8

26.3

142

540

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

52.5

26.3

TNX00, ,

SPAT

5.5

26.2

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

26.1

498

3121

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

4.5

26.1

146

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

26.0

207

947

R53

ICD-10 Finland

Malaise and fatigue

1.8

25.9

471

2908

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.1

25.9

115

393

WX002

NOMESCO Finland

Sedation and analgesia

1.9

25.8

382

2209

9211

FHL

Exploration or removal of diskusprolapse

264.1

25.8

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.8

25.7

218

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

25.6

141

542

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.1

25.5

292

1544

NE1CG, ,

SPAT

10.5

25.4

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.4

25.3

288

R03BA05

ATC

fluticasone; inhalant

1.9

25.3

358

2038

N01

ICPC

Headache

2.3

25.3

220

1045

R06AX27

ATC

desloratadine; oral

1.7

25.2

592

3934

M13.9

ICD-10 Finland

Arthritis, unspecified

2.6

25.1

154

625

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

+∞

25.1

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

25.1

D11

ICPC

Diarrhoea

2.2

25.0

244

1213

M24.2

ICD-10 Finland

Disorder of ligament

6.3

24.9

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

24.8

226

1093

E0000UV, ,

ATC

1.7

24.8

814

5907

SPAT1216

SPAT

Assessment of functional ability

2.1

24.7

278

1459

M01AX01

ATC

nabumetone; oral

3.5

24.7

248

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

24.7

1280

10434

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

131.7

24.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

24.6

122

443

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.7

24.6

220

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.3

24.5

195

891

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

24.3

215

1028

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.8

24.3

208

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

24.3

191

869

D06

ICPC

Abdominal pain localized other

2.3

24.2

192

876

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

7.4

24.2

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

24.2

539

3520

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

24.2

272

1427

C07AB07

ATC

bisoprolol; oral

1.6

24.2

836

6135

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.7

24.0

131

501

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

38.1

24.0

M45

ICD-10 Finland

Ankylosing spondylitis

38.1

24.0

M89.0

ICD-10 Finland

Algoneurodystrophy

8.7

23.7

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.2

23.6

158

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.3

23.5

195

907

RF410, ,

NOMESCO Finland

7.1

23.4

D07AC01

ATC

betamethasone; topical

1.7

23.3

690

4855

NA1BG, ,

SPAT

5.3

23.2

N06AB04

ATC

citalopram; systemic

1.8

23.2

394

2372

J02AC02

ATC

itraconazole; systemic

1.8

23.1

379

2257

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

5.1

23.1

R06AE09

ATC

levocetirizine; oral

2.0

23.0

301

1665

C07AA05

ATC

propranolol; systemic

1.8

22.9

405

2467

Z50.1

ICD-10 Finland

Other physical therapy

2.9

22.9

108

382

R03BA08

ATC

ciclesonide; inhalant

2.3

22.9

193

904

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

22.8

178

806

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

22.8

545

3621

N05CF02

ATC

zolpidem; oral

1.9

22.7

352

2057

M41.9

ICD-10 Finland

Scoliosis, unspecified

9.4

22.7

M15

ICD-10 Finland

Polyarthrosis

2.7

22.6

123

469

ACC51

NOMESCO Finland

Release of median nerve

2.4

22.6

161

700

M01AB08

ATC

etodolac; oral

2.5

22.6

148

619

M75.2

ICD-10 Finland

Bicipital tendinitis

3.9

22.4

173

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

22.3

614

4228

R13

ICD-10 Finland

Dysphagia

2.6

22.3

140

574

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

22.3

353

2077

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

22.2

262

1397

NBG10

NOMESCO Finland

Acromioplastia

4.4

22.1

131

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.1

22.1

232

1185

L05

ICPC

Flank/axilla symptom/complaint

2.6

22.0

133

535

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.8

22.0

189

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.6

22.0

115

RD211, ,

NOMESCO Finland

3.0

22.0

341

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.7

22.0

120

459

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.3

21.9

136

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

21.9

K59.0

ICD-10 Finland

Constipation

2.8

21.8

109

398

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

25.4

21.8

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

21.7

249

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

21.7

253

1343

Z71.8

ICD-10 Finland

Other specified counselling

1.6

21.6

653

4597

C10AX09

ATC

ezetimibe; oral

1.9

21.5

310

1768

M09AX01

ATC

hyaluronic acid; parenteral

3.1

21.5

313

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.8

21.5

109

401

H02AB07

ATC

prednisone; oral

2.0

21.5

260

1398

C10AA07

ATC

rosuvastatin; oral

1.6

21.4

655

4624

N30.0

ICD-10 Finland

Acute cystitis

1.8

21.3

362

2174

R52.1

ICD-10 Finland

Chronic intractable pain

19.1

21.3

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.6

21.3

132

538

B01AB05

ATC

enoxaparin; parenteral

1.7

21.2

587

4039

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.4

21.2

154

676

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

21.1

237

1239

R5110, ,

SPAT

2.3

21.1

175

813

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.6

21.1

129

522

N05CF01

ATC

zopiclone; oral

1.7

21.1

576

3948

WW200, ,

SPAT

1.6

21.1

614

4278

D07AD01

ATC

clobetasol; topical

1.8

21.0

355

2127

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

21.0

260

1408

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

5.1

21.0

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

20.9

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

20.9

416

2618

D01

ICPC

Abdominal pain/cramps general

2.0

20.8

241

1275

D07AC13

ATC

mometasone; topical

1.7

20.7

548

3722

SPAT1263

SPAT

Sampling

1.6

20.7

725

5279

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

20.7

159

715

R96

ICPC

Asthma

2.1

20.6

205

1025

NFL20

NOMESCO Finland

Freeing of muscle of hip or thigh

30.4

20.6

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

30.4

20.6

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

8.3

20.5

DFF00

NOMESCO Finland

Pure tone audiometry

2.1

20.5

210

1062

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

6.8

20.4

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.5

20.4

204

L19

ICPC

Muscle symptom/complaint NOS

3.5

20.4

209

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

20.2

153

683

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

20.2

697

5049

K80

ICPC

Cardiac arrhythmia NOS

2.2

20.2

175

828

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.1

20.1

207

1047

A06AC51

ATC

ispaghula, combinations; oral

2.8

20.1

105

392

R51

ICD-10 Finland

Headache

2.6

20.1

117

462

M23.8

ICD-10 Finland

Other internal derangements of knee

3.1

20.1

272

G44.0

ICD-10 Finland

Cluster headache syndrome

6.8

20.0

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.3

19.9

242

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

19.9

104

389

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

19.8

249

1354

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

+∞

19.8

N03AX09

ATC

lamotrigine; oral

3.0

19.8

317

SPAT1301

SPAT

No procedures

1.7

19.8

517

3493

WX308

NOMESCO Finland

Sacral anesthesy

202.0

19.6

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

202.0

19.6

A03FA02

ATC

cisapride; oral, rectal

2.4

19.6

134

572

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.0

19.5

314

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

19.5

419

2686

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.2

19.5

261

N81.6

ICD-10 Finland

Rectocele

2.2

19.5

174

833

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

19.5

226

1195

R03AK08

ATC

formoterol and beclometasone; inhalant

2.7

19.5

105

399

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

19.4

720

5293

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

19.4

553

3817

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.7

19.4

106

406

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

19.3

114

454

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.4

19.2

141

621

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

19.2

141

621

H02.3

ICD-10 Finland

Blepharochalasis

2.3

19.2

145

647

S29

ICPC

Skin symptom/complaint other

1.7

19.2

397

2518

M19.8

ICD-10 Finland

Other specified arthrosis

2.9

19.1

335

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

19.1

1341

11375

J01AA04

ATC

lymecycline; systemic

1.9

19.0

251

1387

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

18.8

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

18.8

699

5133

K07.60

ICD-10 Finland

Snapping jaw

2.6

18.8

110

436

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

18.8

670

4873

M75

ICD-10 Finland

Shoulder lesions

2.7

18.7

100

378

M25.2

ICD-10 Finland

Flail joint

6.0

18.7

J37.0

ICD-10 Finland

Chronic laryngitis

3.2

18.7

231

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

18.7

450

2970

S76.4

ICD-10 Finland

Injury of other and unspecified muscles and tendons at thigh level

5.6

18.7

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.6

18.6

113

456

M01AC01

ATC

piroxicam; systemic, rectal

2.0

18.6

234

1273

L11

ICPC

Wrist symptom/complaint

2.1

18.6

196

1001

L84

ICPC

Back syndrome without radiat pain

2.9

18.5

307

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

4.5

18.5

102

NG2AA

NOMESCO Finland

Patella X-ray examination

3.3

18.4

218

R74

ICPC

Upper respiratory infection acute

1.6

18.4

613

4384

P01

ICPC

Feeling anxious/nervous/tense

2.0

18.3

217

1156

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

6.9

18.3

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.7

18.2

353

2195

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

4.2

18.2

116

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

18.2

338

M75.5

ICD-10 Finland

Bursitis of shoulder

3.7

18.2

161

N39.3

ICD-10 Finland

Stress incontinence

2.1

18.1

180

898

OAB93, ,

SPAT

2.3

18.1

139

625

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

5.0

18.1

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

18.0

731

5463

S06.0

ICD-10 Finland

Concussion

2.1

17.9

185

936

R12

ICD-10 Finland

Heartburn

2.1

17.9

175

868

SPAT1312

SPAT

General health counselling

1.6

17.8

539

3760

NF1BA, ,

SPAT

4.9

17.8

H93.1

ICD-10 Finland

Tinnitus

2.3

17.8

145

668

M22.4

ICD-10 Finland

Chondromalacia patellae

3.4

17.7

188

L18

ICPC

Muscle pain

2.8

17.7

337

A06AD11

ATC

lactulose; oral

1.9

17.7

229

1256

S70.0

ICD-10 Finland

Contusion of hip

3.0

17.7

271

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

17.7

265

1525

N17

ICPC

Vertigo/dizziness

1.9

17.6

243

1361

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.3

17.6

138

626

A99

ICPC

Disease/condition unspecnature/site

2.0

17.4

206

1095

M01AB51

ATC

indometacin, combinations; oral, rectal

4.3

17.4

103

J01EA01

ATC

trimethoprim; systemic

1.6

17.3

501

3453

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

17.3

187

962

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

17.3

586

4192

P06

ICPC

Sleep disturbance

1.9

17.3

242

1361

C01CA24

ATC

epinephrine; parenteral

2.3

17.3

133

598

XKD00

NOMESCO Finland

Uroflowmetry

2.1

17.2

177

894

J01FA15

ATC

telithromycin; oral

2.0

17.1

197

1037

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.2

17.1

223

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

17.1

265

1541

TQW40, ,

SPAT

2.0

17.0

204

1089

SFA30

NOMESCO Finland

Three-surface restoration

1.5

17.0

806

6203

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.0

17.0

204

1090

N03AF01

ATC

carbamazepine; oral, rectal

2.7

17.0

345

N02AC04

ATC

dextropropoxyphene; oral

3.9

16.9

127

WX290

NOMESCO Finland

Other blockage of nerve

1.5

16.9

862

6734

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.8

16.9

317

H01

ICPC

Ear pain/earache

1.9

16.9

221

1216

SFA20

NOMESCO Finland

Two-surface restoration

1.5

16.9

1096

9004

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

16.8

211

1144

K08.80

ICD-10 Finland

Toothache NOS

2.0

16.8

188

979

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.8

16.8

318

J05AB01

ATC

aciclovir; systemic

1.6

16.8

429

2866

N06AB10

ATC

escitalopram; oral

1.7

16.8

368

2363

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

16.8

102

412

M70.9

ICD-10 Finland

Unspecified soft tissue disorder related to use, overuse and pressure

6.3

16.8

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.2

16.7

145

685

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

16.7

178

911

SPAT1260

SPAT

Consultation of another employee

1.8

16.7

291

1752

R00.2

ICD-10 Finland

Palpitations

2.1

16.7

165

822

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

16.6

120

525

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

16.6

119

519

RF420, ,

NOMESCO Finland

5.3

16.6

Z3226

NOMESCO Finland

Physiotherapist

1.8

16.6

301

1834

OAA65, ,

SPAT

1.7

16.6

343

2168

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.8

16.5

293

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.7

16.5

148

R1250, ,

SPAT

3.1

16.5

228

M77.0

ICD-10 Finland

Medial epicondylitis

3.4

16.5

177

K02.1

ICD-10 Finland

Caries of dentine

1.5

16.4

1069

8763

EC1VA, ,

NOMESCO Finland

2.5

16.4

103

423

S49.9

ICD-10 Finland

Unspecified injury of shoulder and upper arm

4.2

16.3

104

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

5.9

16.2

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

16.2

135

628

A98

ICPC

Health maint/preventive medicine

5.0

16.1

1875

17888

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.4

16.1

170

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

24.7

16.0

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

16.0

158

786

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

4.3

16.0

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.4

16.0

111

477

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.1

16.0

110

NFF25

NOMESCO Finland

Cleaning of hip joint, arthroscopic

21.1

16.0

J01DC02

ATC

cefuroxime; systemic

2.4

16.0

117

515

OAA81, ,

SPAT

2.8

16.0

287

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.7

15.8

334

R03BA01

ATC

beclometasone; inhalant

1.8

15.8

248

1445

P01BA02

ATC

hydroxychloroquine; oral

2.1

15.8

165

839

S80.0

ICD-10 Finland

Contusion of knee

2.1

15.7

152

751

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

15.7

125

571

RF210, ,

NOMESCO Finland

3.4

15.7

173

SPAT1229

SPAT

Assessment of need for aid

2.3

15.7

118

526

G50.1

ICD-10 Finland

Atypical facial pain

4.2

15.6

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

15.6

308

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.0

15.6

236

G04BD09

ATC

trospium; oral

3.5

15.5

159

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

161.3

15.5

G04BD08

ATC

solifenacin; oral

2.3

15.4

120

542

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

15.4

168

867

OAB71, ,

SPAT

6.7

15.3

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.9

15.3

189

1019

R03BA02

ATC

budesonide; inhalant

1.7

15.3

326

2073

J01DA09

ATC

[U] cefadroxil

1.6

15.3

474

3309

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.8

15.2

123

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

15.2

707

5383

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.6

15.2

371

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.8

15.2

119

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

15.1

215

1214

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

15.1

106

458

S15

ICPC

Foreign body in skin

2.2

15.1

125

580

SFA10

NOMESCO Finland

One-surface restoration

1.5

15.1

998

8151

W19

ICD-10 Finland

Unspecified fall

2.0

15.1

162

832

N05BA12

ATC

alprazolam; oral

1.9

15.0

191

1040

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

15.0

237

1383

M18.9

ICD-10 Finland

Arthrosis of first carpometacarpal joint, unspecified

4.4

15.0

S86.0

ICD-10 Finland

Injury of Achilles tendon

3.6

15.0

134

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

14.9

516

3687

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.2

14.9

131

623

R01AD11

ATC

triamcinolone; nasal

2.0

14.9

169

885

M76

ICD-10 Finland

Enthesopathies of lower limb, excluding foot

6.8

14.9

A11

ICPC

Chest pain NOS

2.1

14.9

152

766

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.9

14.8

259

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

57.1

14.8

N06AX12

ATC

bupropion; oral

2.2

14.7

124

579

D02

ICPC

Abdominal pain epigastric

2.2

14.7

126

593

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

14.6

324

R06AX22

ATC

ebastine; oral

1.7

14.6

346

2259

R09

ICPC

Sinus symptom/complaint

2.0

14.6

162

841

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

14.6

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

80.7

14.6

J01MA12

ATC

levofloxacin; systemic

1.7

14.6

304

1920

R03AC13

ATC

formoterol; inhalant

2.4

14.6

409

P03

ICPC

Feeling depressed

2.0

14.6

165

863

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

12.0

14.6

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

14.6

153

779

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.6

14.5

132

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

14.5

329

2124

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

14.5

114

518

H02

ICPC

Hearing complaint

1.8

14.4

260

1577

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

14.4

135

658

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

14.4

100

430

ZXA00

NOMESCO Finland

Right side

1.6

14.4

431

2978

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

14.4

375

R83

ICPC

Respiratory infection other

1.6

14.3

467

3290

ZXA05

NOMESCO Finland

Left side

1.6

14.3

397

2694

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

14.3

128

613

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

14.2

799

6294

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

14.2

384

2588

R50.9

ICD-10 Finland

Fever, unspecified

1.8

14.2

254

1537

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

14.2

111

503

SPAT1211

SPAT

Application of soft bandage

2.0

14.2

150

766

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

5.7

14.2

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

14.1

182

995

XKC03

NOMESCO Finland

Water cystometry

3.0

14.1

211

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.6

14.1

130

R01AD01

ATC

beclometasone; nasal

1.7

14.1

288

1808

L82

ICD-10 Finland

Seborrhoeic keratosis

1.6

14.1

383

2586

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

13.9

671

5124

K05

ICPC

Irregular heartbeat other

2.8

13.9

251

N05AH04

ATC

quetiapine; oral

1.7

13.9

281

1758

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

13.9

225

1323

R07.0

ICD-10 Finland

Pain in throat

2.1

13.8

130

636

XA420

NOMESCO Finland

Extensive sleep examination

5.7

13.7

NA3CG, ,

SPAT

5.7

13.7

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.9

13.6

232

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.3

13.6

153

R03BC03

ATC

nedocromil; inhalant

2.1

13.6

139

701

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

13.6

108

493

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

13.6

N05BA01

ATC

diazepam; systemic, rectal

1.8

13.6

213

1240

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

13.6

170

921

NF1AE, ,

SPAT

5.9

13.5

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

34.3

13.5

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

13.5

424

M01AB01

ATC

indometacin; systemic, rectal

2.3

13.5

107

488

J01DA06

ATC

[U] cefuroxime

1.7

13.5

261

1614

SPAT1360

SPAT

Extensive global examination

2.2

13.5

119

567

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

141.0

13.5

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

13.5

415

2882

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

4.2

13.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

13.4

163

874

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

13.4

572

4260

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.9

13.3

218

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

3.7

13.3

116

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

13.3

471

3371

C08CA01

ATC

amlodipine; oral

1.5

13.3

636

4841

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

13.9

13.2

-1, ,

NOMESCO Finland

1.5

13.2

564

4196

N06AX26

ATC

vortioxetine; oral

2.1

13.2

127

626

C10AC01

ATC

colestyramine; oral

3.1

13.2

182

M53.2

ICD-10 Finland

Spinal instabilities

40.4

13.2

M65.3

ICD-10 Finland

Trigger finger

2.3

13.2

103

467

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

13.1

152

801

S59

ICPC

Skin, Other therap proced/minor surg NEC

3.1

13.1

177

S21

ICPC

Skin texture symptom/complaint

1.7

13.1

277

1753

M19

ICD-10 Finland

Other arthrosis

3.2

13.0

157

H57.1

ICD-10 Finland

Ocular pain

2.6

13.0

307

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

13.0

303

1965

R06AX13

ATC

loratadine; oral

1.7

13.0

284

1812

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

13.0

138

706

L10

ICPC

Elbow symptom/complaint

2.2

12.9

104

477

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

12.9

255

1584

OAB72, ,

SPAT

3.9

12.9

100

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

12.9

101

458

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

4.9

12.9

U01

ICPC

Dysuria/painful urination

2.0

12.9

152

807

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.8

12.8

105

J01CA08

ATC

pivmecillinam; oral

1.4

12.8

849

6858

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.3

12.8

149

WZC00, ,

SPAT

1.7

12.7

260

1631

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.1

12.7

165

D01BA02

ATC

terbinafine; oral

1.5

12.7

427

3019

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.0

12.6

192

NB1AD

NOMESCO Finland

Shoulder CT examination

3.7

12.6

111

RF220, ,

NOMESCO Finland

4.8

12.6

J01MA06

ATC

norfloxacin; oral

1.7

12.6

249

1547

SDA03

NOMESCO Finland

Periodontal treatment

1.4

12.5

775

6173

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

12.5

130

659

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

17.4

12.5

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

12.5

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

12.5

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

12.5

110

524

Z30.2

ICD-10 Finland

Sterilization

1.8

12.5

211

1255

L20

ICPC

Joint symptom/complaint NOS

2.5

12.5

326

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.3

12.4

407

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

130.8

12.4

Q65.88

ICD-10 Finland

Other congenital deformities of hip

130.8

12.4

SPAT1043

SPAT

Audiometry

1.9

12.4

163

896

M50

ICD-10 Finland

Cervical disc disorders

13.3

12.4

N06AB03

ATC

fluoxetine; oral

1.8

12.4

215

1288

D82

ICPC

Teeth/gum disease

1.4

12.4

685

5343

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.3

12.4

440

A02BA04

ATC

nizatidine; systemic

2.1

12.4

120

593

NH3AA, ,

SPAT

2.1

12.3

123

614

T78.4

ICD-10 Finland

Allergy, unspecified

2.4

12.3

365

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.3

12.3

448

R1250

NOMESCO Finland

Evaluation of functional capability

3.1

12.3

163

U02

ICPC

Urinary frequency/urgency

1.6

12.3

282

1822

G03DC02

ATC

norethisterone; oral

1.7

12.3

249

1558

H29

ICPC

Ear symptom/complaint other

1.7

12.3

223

1354

ZA1.0

ICD-10 Finland

Shoulder region

3.2

12.2

153

ZZH40

NOMESCO Finland

Substitute of bone

9.0

12.2

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.3

12.2

143

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

12.2

447

3216

J05AB11

ATC

valaciclovir; oral

1.6

12.0

272

1749

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.2

12.0

104

492

S79.9

ICD-10 Finland

Unspecified injury of hip and thigh

5.7

12.0

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.2

11.9

145

L57.0

ICD-10 Finland

Actinic keratosis

1.8

11.9

180

1034

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

13.5

11.9

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

4.0

11.9

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

11.9

301

1991

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

3.1

11.9

161

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

11.8

165

925

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

11.8

217

1320

K02.0

ICD-10 Finland

Caries limited to enamel

1.6

11.8

349

2393

M01AC02

ATC

tenoxicam; systemic, rectal

2.3

11.8

372

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

4.2

11.8

R29

ICPC

Respiratory symptom/complaint other

2.0

11.8

123

625

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

11.8

178

KMAK, ,

NOMESCO Finland

1.4

11.8

890

7320

M77.5

ICD-10 Finland

Other enthesopathy of foot

5.2

11.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

11.7

135

710

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

11.7

418

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

3.3

11.7

137

C09CA06

ATC

candesartan; oral

1.5

11.7

443

3206

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

11.6

165

930

NFE15

NOMESCO Finland

Plastic repair of capsule or ligament of hip joint

65.4

11.6

D19

ICPC

Teeth/gum symptom/complaint

1.4

11.6

569

4330

WX702

NOMESCO Finland

Supraglottic ventilation device

2.1

11.6

110

540

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.4

11.5

118

JAH01

NOMESCO Finland

Laparoscopy

2.3

11.5

395

SXC05

NOMESCO Finland

Other oral or dental procedure

2.1

11.5

116

582

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

5.1

11.5

N80.0

ICD-10 Finland

Endometriosis of uterus

3.0

11.5

170

J20

ICD-10 Finland

Acute bronchitis

1.8

11.4

184

1078

M62.6

ICD-10 Finland

Muscle strain

2.7

11.4

220

SGA01

NOMESCO Finland

Emergency treatment

1.6

11.4

288

1902

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.7

11.4

A04

ICPC

Weakness/tiredness general

1.7

11.4

251

1604

SPAT1359

SPAT

Use of symptom diary

3.1

11.3

155

NB1BG, ,

SPAT

2.9

11.3

182

JN3AE, ,

SPAT

2.3

11.3

379

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

11.3

233

1463

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.6

11.3

239

NH4AE

NOMESCO Finland

Achilles tendon ultrasound examination

10.6

11.3

H92.0

ICD-10 Finland

Otalgia

2.1

11.2

114

573

L90

ICPC

Osteoarthrosis of knee

2.0

11.2

130

685

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

11.2

140

757

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.9

11.2

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.2

11.2

426

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.1

11.2

151

XQ802

NOMESCO Finland

Epicutan test

2.3

11.2

381

G04BD11

ATC

fesoterodine; oral

2.9

11.2

178

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.8

11.1

206

TNF10

NOMESCO Finland

Puncture of hip joint

20.2

11.1

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

660

2859

3.01

105.00

1.5

1.3

9.51

13.51

u/ml

0.78

227

1128

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

667

3104

2.77

90.50

1.4

1.3

19.52

31.51

iu/ml

3.23

200

958

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1647

12271

3.59

83.69

5.8

4.0

10.97

12.33

mm/h

4.49

1556

11453

(3013512) EKG study

917

5676

2.19

59.90

3.7

3.3

—

0.71

—

(3018010) Neutrophils/Leukocytes in Blood

1143

7792

2.17

57.36

6.0

6.3

55.75

57.10

4.00

1079

7453

(40768797) Stomach Pathology biopsy report

467

2247

2.43

55.04

1.3

1.2

—

(3019069) Monocytes/Leukocytes in Blood

1125

7733

2.12

53.80

6.2

6.4

8.72

8.74

0.09

1043

7261

(3037522) Nuclear Ab [Titer] in Serum

475

2330

2.39

53.43

1.5

1.4

544.22

602.76

titre

0.26

109

536

(3022096) Basophils/Leukocytes in Blood

1122

7720

2.11

53.31

6.3

6.4

0.76

0.70

4.71

1039

7227

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

775

4647

2.13

53.19

2.3

2.0

165.14

193.12

u/l

0.57

745

4382

(3002030) Lymphocytes/Leukocytes in Blood

1145

7943

2.11

53.17

6.0

6.3

29.95

28.15

8.10

1080

7546

(3006504) Eosinophils/Leukocytes in Blood

1120

7718

2.10

52.78

6.1

6.3

2.92

2.81

0.89

1035

7240

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1603

12777

2.64

52.45

8.3

8.2

75.29

79.66

u/l

3.35

1524

12108

(3019198) Lymphocytes [#/volume] in Blood

1189

8475

2.08

49.91

6.0

6.2

1.94

1.91

e9/l

0.40

1072

7452

(3001604) Monocytes [#/volume] in Blood

1169

8299

2.06

49.37

5.9

6.2

0.56

e9/l

0.04

1025

7106

(3006315) Basophils [#/volume] in Blood

1170

8309

2.06

49.36

6.0

6.2

0.04

e9/l

2.07

1027

7114

(3013115) Eosinophils [#/volume] in Blood

1199

8594

2.07

49.28

6.1

6.4

0.19

0.18

e9/l

0.37

1069

7479

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1151

8188

2.03

47.54

6.4

6.9

1.23

1.22

mmol/l

9.50

970

7043

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

664

3917

2.07

46.10

1.4

1.3

2.02

1.94

u/ml

0.04

160

1008

(3032080) INR in Blood by Coagulation assay

1012

6963

1.97

45.01

10.9

12.9

1.12

1.21

inr

7.25

841

5739

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1123

8023

1.98

44.56

2.9

2.4

81.41

78.65

nmol/l

2.71

1000

7298

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

865

5684

1.96

43.59

3.6

3.2

27.62

53.87

ng/l

1.12

576

3751

(3013826) Glucose [Moles/volume] in Serum or Plasma

1246

9290

1.99

42.91

4.4

4.5

6.23

6.63

mmol/l

14.74

1199

8793

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1632

13511

2.48

42.27

5.6

4.6

14.59

14.70

pmol/l

1.13

1494

12471

(3019225) pH of Specimen

346

1626

2.38

41.89

4.0

4.1

7.37

7.36

0.86

223

1148

(3008898) HLA-B27 [Presence]

150

464

3.42

39.92

1.1

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

414

2142

2.19

39.66

5.5

4.8

33.01

32.99

0.01

263

1420

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

243

998

2.65

39.08

1.4

1.3

57.92

56.44

au/ml

0.03

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1798

15775

3.65

38.98

7.0

5.5

1.76

1.92

mu/l

7.07

1662

14639

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

764

4961

1.90

38.57

2.6

2.5

56.07

64.34

u/l

3.41

696

4587

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1020

7278

1.87

38.16

5.8

6.2

1.23

1.22

mmol/l

6.46

905

6720

(3021960) Folate [Moles/volume] in Serum or Plasma

707

4499

1.91

37.79

1.8

1.6

21.97

21.00

nmol/l

0.92

555

3774

(3031040) Bacteria [#/volume] in Urine by Automated count

1346

10518

1.96

37.77

5.7

4.2

765.50

2371.14

e6/l

—

142

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1831

16361

4.37

36.25

17.2

13.7

16.87

23.54

mg/l

19.11

1556

13138

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

252

1095

2.50

35.93

2.7

2.4

18.56

21.77

au/ml

0.24

130

(3007164) IgA [Mass/volume] in Serum or Plasma

574

3458

1.95

35.79

1.5

1.4

2.35

2.32

g/l

0.13

319

2119

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1037

7544

1.83

35.38

2.9

2.7

—

estimate

—

(3017732) Neutrophils [#/volume] in Blood

395

2094

2.12

35.12

2.9

3.3

3.67

4.15

e9/l

3.02

321

1832

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

994

7219

1.79

33.33

2.3

2.0

104.54

97.95

pmol/l

3.03

456

3584

(3013650) Neutrophils [#/volume] in Blood by Automated count

1221

9472

1.81

32.26

7.3

10.2

3.85

3.95

e9/l

0.93

1084

8197

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1067

7996

1.76

31.32

3.7

2.9

91.77

110.94

ug/l

5.61

977

7496

(3045414) Leukocytes [Presence] in Urine

295

1455

2.22

31.22

2.2

2.1

0.00

0.03

estimate

1.06

303

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1134

8667

1.77

30.88

5.4

6.9

9.86

11.19

umol/l

3.69

1077

8271

(3019550) Sodium [Moles/volume] in Serum or Plasma

1850

16875

4.81

30.66

19.2

16.0

139.94

139.78

mmol/l

2.24

1816

16520

(3023103) Potassium [Moles/volume] in Serum or Plasma

1851

16909

4.82

30.21

19.3

16.2

3.96

3.95

mmol/l

1.49

1812

16509

(3045424) Erythrocytes [Presence] in Urine

188

773

2.59

29.90

2.1

0.00

0.02

estimate

0.88

235

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1801

16204

3.18

29.57

16.7

13.7

81.19

81.24

ml/min/173m2

0.04

1695

14915

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

549

3442

1.84

29.22

1.7

0.79

1.21

mg/l

5.26

418

2686

(3026493) Urate [Moles/volume] in Serum or Plasma

623

4072

1.79

28.80

2.5

318.51

327.36

umol/l

1.49

538

3647

(40768804) Tissue Pathology biopsy report

985

7361

1.70

27.88

2.3

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

368

2063

1.97

27.40

2.4

2.3

114.42

118.24

ug/g

0.08

274

1646

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1388

11436

1.80

27.24

3.9

3.1

40.62

45.30

u/l

1.51

1286

10756

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1756

15714

2.57

26.93

6.9

6.0

38.36

38.92

mmol/mol

2.74

1624

14714

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

646

4339

1.74

26.75

2.7

3.0

723.97

1131.53

ng/l

3.38

535

3707

(3021601) Nitrite [Presence] in Urine by Test strip

1092

8469

1.68

26.19

4.4

3.5

0.00

estimate

0.50

285

1740

(3036481) Cortisol [Moles/volume] in Serum or Plasma

285

1482

2.09

26.05

2.1

2.3

342.46

384.64

nmol/l

2.88

259

1388

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

134

497

2.83

26.02

1.4

1.3

16.21

8.51

u/ml

0.24

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

140

532

2.76

25.97

1.4

1.2

7.76

39.60

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1788

16183

2.81

25.96

6.0

4.9

5.78

5.85

mmol/l

2.11

1627

14884

(3022145) Colonoscopy Study observation

346

1943

1.95

25.47

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

133

497

2.80

25.46

1.4

1.2

9.58

2.00

u/ml

—

(3009261) Glucose [Presence] in Urine by Test strip

1103

8648

1.66

24.72

4.4

3.6

0.01

0.19

estimate

0.48

281

1691

(3035350) Ketones [Presence] in Urine by Test strip

1093

8551

1.66

24.69

4.4

3.5

4.35

2.45

estimate

0.17

288

1792

(3023420) DNA double strand Ab [Units/volume] in Serum

163

705

2.44

23.17

1.9

1.8

6.29

6.79

iu/ml

0.09

163

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

595

4039

1.69

22.97

2.5

2.2

2.71

2.81

mg/l

0.62

518

3491

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

964

7400

1.62

22.73

2.1

1.9

1.36

1.33

mmol/l

0.47

771

6206

(36660697) Celiac disease serology panel - Serum

264

1401

2.03

22.66

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

584

3989

1.67

21.80

2.4

2.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1876

17673

6.31

21.50

22.4

18.1

73.04

72.52

umol/l

0.40

1854

17465

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1804

16644

2.69

20.63

6.1

4.9

1.56

1.55

mmol/l

0.79

1659

15492

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1807

16733

2.67

19.61

6.1

5.0

4.81

mmol/l

0.05

1664

15674

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1822

16947

2.88

19.47

6.7

5.6

2.79

2.82

mmol/l

0.59

1674

15811

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1244

10352

1.59

19.33

3.1

2.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1739

15860

2.15

19.32

4.9

4.2

1.31

1.26

mmol/l

1.72

1576

14618

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1866

17607

4.55

19.25

14.1

11.6

25.47

24.83

u/l

0.66

1808

17132

(3025941) Bacteria identified in Stool by Culture

168

802

2.20

18.93

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

200

1045

2.02

17.77

1.4

1.3

169.52

159.17

u/ml

0.08

189

966

(3024561) Albumin [Mass/volume] in Serum or Plasma

924

7301

1.52

17.33

4.7

5.0

36.71

35.80

g/l

6.39

845

6869

(3044640) Blood type and Crossmatch panel - Blood

704

5252

1.54

17.25

2.5

2.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

172

3.51

17.21

1.1

1.2

—

30.82

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

106

445

2.46

16.06

1.5

1.4

298.81

294.92

ug/g

0.07

261

(3015171) Extractable nuclear Ab [Units/volume] in Serum

136

639

2.22

15.92

1.4

1.2

0.92

2.01

u/ml

—

(3022948) Iron [Moles/volume] in Serum or Plasma

398

2648

1.64

15.71

2.5

13.64

13.22

umol/l

0.56

362

2474

(3041096) Erythrocytes [Presence] in Urine by Automated

628

4658

1.52

15.39

3.8

3.1

0.21

0.22

estimate

0.01

234

1347

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

400

2.50

15.28

1.4

1.2

53.85

39.38

u/ml

—

(3007461) Platelets [#/volume] in Blood

1885

18118

6.90

14.68

27.4

21.5

260.23

258.54

e9/l

0.58

1857

17732

(3025159) Blasts/Leukocytes in Blood

237

1393

1.80

14.64

5.0

0.05

0.36

0.72

339

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1885

18121

6.87

14.61

27.2

21.5

91.60

91.06

6.80

1867

17924

(3030467) Casts [#/volume] in Urine by Automated count

581

4277

1.52

14.60

3.4

2.9

0.29

0.45

e6/l

2.04

462

2996

(3035941) MCH [Entitic mass]

1885

18123

6.86

14.56

27.2

21.4

30.40

30.24

4.61

1867

17926

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1885

18123

6.86

14.56

27.7

21.9

40.41

40.56

0.17

1867

17911

(3026361) Erythrocytes [#/volume] in Blood

1885

18124

6.85

14.54

27.4

21.5

4.44

4.46

e12/l

0.87

1856

17677

(3010813) Leukocytes [#/volume] in Blood

1885

18124

6.85

14.54

27.4

21.6

6.61

6.57

e9/l

0.33

1857

17670

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

137

670

2.13

14.50

2.5

2.2

39.09

39.04

u/l

0.01

125

606

(3004616) Nuclear Ab [Presence] in Serum

219

2.99

14.43

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

1885

18130

6.80

14.40

27.5

21.6

134.36

133.91

g/l

0.89

1870

17936

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

111

505

2.27

14.05

2.9

3.7

25.00

25.01

mmol/l

0.01

100

466

(3009343) pH of Capillary blood

168

897

1.96

13.98

2.9

3.6

7.42

0.04

139

741

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

171

922

1.94

13.83

2.9

3.6

5.09

5.19

kpa

1.18

164

892

(3005719) IgG [Mass/volume] in Serum or Plasma

215

1251

1.81

13.71

2.4

2.9

9.80

10.71

g/l

3.16

195

1159

(3000850) Epithelial cells [#/volume] in Urine

466

3310

1.54

13.68

2.7

2.5

6.47

7.31

e6/l

0.54

438

2989

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

110

507

2.24

13.50

1.6

1.18

1.20

g/l

0.20

102

483

(3002179) Metamyelocytes/Leukocytes in Blood

230

1377

1.76

13.31

4.5

0.37

0.68

2.49

403

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

148

776

1.98

12.97

2.7

3.5

1.49

1.98

mmol/l

1.09

116

604

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

190

1083

1.84

12.94

1.6

—

(3022313) Gas panel - Capillary blood

130

651

2.07

12.94

2.9

3.6

—

(3021440) Promyelocytes/Leukocytes in Blood

229

1388

1.74

12.67

4.6

4.7

0.00

0.12

8.04

371

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

105

490

2.21

12.52

1.6

0.24

g/l

0.13

464

(3004789) Transferrin [Mass/volume] in Serum or Plasma

356

2426

1.58

12.44

2.5

2.46

2.33

g/l

4.57

316

2245

(3022621) pH of Urine by Test strip

212

1266

1.76

12.35

2.5

2.6

6.00

6.07

0.57

127

823

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

793

6355

1.43

12.34

4.2

3.4

2.12

0.12

estimate

0.46

236

1394

(3020630) Protein [Mass/volume] in Serum or Plasma

204

1209

1.77

12.20

2.0

2.8

66.43

66.38

g/l

0.04

186

1122

(3002582) Erythrocytes [#/volume] in Urine

643

4968

1.45

12.19

3.6

3.0

47.04

95.90

e6/l

1.26

523

3641

(3021589) Normoblasts [#/volume] in Blood

910

7487

1.41

12.14

12.3

10.6

0.01

0.00

e9/l

0.40

764

6092

(3017181) Myelocytes/Leukocytes in Blood

234

1444

1.71

12.12

4.6

4.7

0.48

0.98

3.42

427

(3014051) Protein [Presence] in Urine by Test strip

616

4733

1.45

11.99

3.3

2.8

0.00

0.03

—

110

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

330

2229

1.58

11.94

2.5

22.17

22.85

0.44

296

2070

(3006571) Granulocytes/Leukocytes in Synovial fluid

151

3.17

11.84

1.3

1.7

45.37

60.26

1.25

104

(3013139) Helicobacter pylori Ag [Presence] in Stool

194

1143

1.78

11.83

1.3

—

(3018418) pH of Serum or Plasma

628

4868

1.43

11.56

4.0

4.2

7.39

7.40

2.22

495

3428

(3019309) Folate [Moles/volume] in Red Blood Cells

354

2449

1.55

11.49

1.8

1.7

1085.60

1139.67

nmol/l

0.50

247

1862

(3003327) Ova and parasites identified in Stool by Light microscopy

116

583

2.05

11.45

1.8

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

750

6020

1.41

11.27

2.6

3.7

2.36

mmol/l

0.25

659

5549

(4024509) Urine culture

137

739

1.92

11.06

2.5

1.8

—

(40768443) Skin Pathology biopsy report

135

727

1.92

10.96

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

153

3.06

10.95

2.6

2.0

18.53

23.40

mg/l

0.32

(3015736) pH of Urine

825

6755

1.39

10.92

3.6

3.1

6.11

6.21

1.92

482

3769

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

464

3431

1.47

10.86

1.7

74456992.13

38547533.51

pmol/l

0.37

368

2877

(3029937) Albumin [Presence] in Urine by Test strip

588

4552

1.42

10.74

4.5

3.7

0.00

estimate

1.28

272

1642

(3018095) Leukocytes [#/volume] in Urine

726

5833

1.40

10.69

4.3

3.6

83.79

117.26

e6/l

0.86

555

3890

(3010838) Calcium [Moles/time] in 24 hour Urine

321

2.36

10.51

1.8

2.0

4.66

5.34

mmol/24h

1.15

286

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

3.59

10.49

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

200

1230

1.70

10.46

2.1

1.9

—

(3026008) Bacteria identified in Urine by Culture

633

4992

1.40

10.31

3.5

2.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

4.24

10.10

1.1

1.0

13.15

4.94

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

216

1370

1.65

10.04

2.1

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

363

2.23

9.83

1.5

1.6

5977.98

12708.93

e6/l

1.67

251

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

400

2926

1.47

9.78

1.7

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

484

3690

1.42

9.42

4.8

4.6

—

(3000494) Fungus identified in Specimen by Culture

293

2027

1.53

9.39

1.5

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

478

2.04

9.38

1.3

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

135

765

1.82

9.37

2.6

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

708

5756

1.37

9.36

3.2

28.65

32.94

u/l

1.91

669

5444

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

187

1165

1.67

9.31

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

167

1010

1.72

9.28

1.9

1.8

1.59

1.48

g/l

0.14

149

934

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

393

2.14

9.21

1.3

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

255

1719

1.56

9.18

5.1

5.8

—

(3044889) 12 lead EKG panel

1304

11667

1.38

9.17

4.2

3.7

—

0.28

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

281

1938

1.53

9.12

2.7

2.6

5.33

7.93

umol/l

4.93

238

1704

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.37

9.05

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.37

9.05

1.5

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

253

1718

1.55

8.80

1.9

1.7

—

(3026782) Osmolality of Urine

386

2868

1.43

8.58

2.8

2.6

502.11

515.92

mosm/kgh2o

0.67

350

2506

(3009508) Creatinine [Moles/volume] in Urine

686

5609

1.35

8.54

3.3

3.4

6.99

7.07

mmol/l

0.18

548

4744

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.48

8.37

1.8

1.5

0.36

0.31

ug/l

0.38

(3024522) Salmonella sp identified in Specimen by Organism specific culture

214

2.47

8.34

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

214

2.47

8.34

1.4

1.5

—

(3012516) Albumin [Mass/volume] in Urine

654

5326

1.35

8.31

3.2

3.5

30.26

41.88

mg/l

1.10

340

3201

(3025468) Yersinia sp identified in Specimen by Organism specific culture

203

2.50

8.26

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

203

2.50

8.26

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

216

2.45

8.19

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

204

2.49

8.18

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

188

1216

1.61

8.06

3.2

3.6

4.46

4.48

pmol/l

0.11

160

1096

(3042936) Bacteria identified in Isolate by Culture

297

2124

1.47

8.04

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

108

606

1.83

7.77

1.7

1.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

117

2.94

7.71

1.6

1.3

0.92

1.60

u/ml

0.31

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

435

1.97

7.71

2.6

2.3

10.46

12.39

mg/l

1.28

407

(3049717) Cytology report of Urine Cyto stain

485

1.92

7.68

3.0

2.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

198

1314

1.57

7.61

1.3

1.2

218.34

143.67

u/ml

1.17

506

(3020682) Albumin/Creatinine [Ratio] in Urine

659

5429

1.33

7.58

3.7

4.1

6.06

7.89

mg/mmol

0.66

337

3232

(3014765) Yersinia sp identified in Stool by Organism specific culture

391

2.01

7.47

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

394

1.99

7.32

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

194

1296

1.55

7.24

3.7

3.5

1.24

1.23

mmol/l

0.94

172

1104

(4062490) Immunoglobulin typing, IgG

144

2.67

7.24

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

145

2.65

7.15

1.3

1.4

0.32

0.43

g/l

1.84

107

(3028192) IgG subclass 2 [Mass/volume] in Serum

145

2.65

7.15

1.3

1.4

2.23

2.89

g/l

2.94

108

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

535

1.84

7.09

1.3

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

146

2.64

7.06

1.3

6.46

7.13

g/l

0.47

107

(40758558) Short blood count panel - Blood

618

5087

1.32

7.03

5.5

6.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

111

651

1.75

6.92

2.3

2.2

10.74

12.04

nmol/l

0.87

593

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

148

2.60

6.88

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

254

2.20

6.85

1.5

1.7

0.59

0.81

g/l

0.97

198

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

496

1.83

6.59

1.9

2.2

169.10

947.90

ug/l

1.15

470

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

164

2.47

6.53

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

141

2.58

6.46

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

141

2.58

6.46

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

136

2.60

6.38

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

347

2655

1.38

6.35

2.8

3.5

0.83

0.82

mmol/l

1.25

312

2507

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

183

1244

1.52

6.32

3.4

3.8

77.78

87.65

ng/l

1.08

153

1062

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

221

1563

1.47

6.29

2.7

2.2

28.76

42.35

u/l

3.34

179

1324

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

111

671

1.69

6.23

1.5

1.8

3.10

4.40

mg/l

0.74

492

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

390

1.91

6.18

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

279

2.08

6.16

1.5

1.4

31.26

32.85

u/l

0.11

233

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

530

1.77

6.13

1.9

2.4

9.20

10.36

g/l

1.92

479

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

104

621

1.71

6.11

1.7

1.6

11.16

14.18

u/ml

0.32

162

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

137

880

1.60

6.08

1.1

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

556

1.75

6.00

1.7

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

136

2.53

5.87

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

142

2.49

5.87

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

545

1.74

5.85

2.0

2.4

0.57

1.08

g/l

1.08

469

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

583

1.72

5.85

2.1

2.4

2.82

2.91

g/l

0.38

537

(3023520) Reticulocytes [#/volume] in Blood

180

1242

1.50

5.80

2.4

2.8

62.88

71.01

e9/l

3.70

144

912

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

149

2.44

5.80

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

132

2.53

5.71

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

618

1.69

5.70

2.0

2.3

4.29

4.25

g/l

0.20

571

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

618

1.69

5.70

2.0

2.3

7.60

7.35

g/l

0.76

571

(3004716) Salmonella sp identified in Stool by Organism specific culture

120

760

1.62

5.65

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

202

2.21

5.62

1.2

1.4

—

nmol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

478

1.77

5.56

1.4

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

273

2054

1.38

5.51

5.0

5.9

1.02

1.04

mmol/l

0.47

251

1899

(3023368) Bacteria identified in Blood by Culture

496

4074

1.29

5.50

3.9

4.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.64

5.48

1.1

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

618

1.67

5.46

2.0

2.3

3.66

3.72

g/l

0.18

572

(3032057) Clostridioides difficile [Presence] in Stool

4.88

5.43

1.7

2.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

362

2861

1.33

5.30

4.3

3.4

51.18

392.23

ng/l

6.00

245

2110

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

318

2467

1.35

5.28

2.0

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

219

1600

1.42

5.24

3.2

3.0

—

(3033099) Centromere Ab [Titer] in Serum

4.60

5.17

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

474

1.74

5.16

2.3

3.6

28.10

57.97

mg/l

1.73

413

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

408

1.79

5.12

1.2

1.1

3.54

4.70

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

468

1.74

5.11

2.0

2.9

24.75

25.28

mmol/l

0.92

460

(3028433) Virus identified in Specimen by Culture

3.42

5.03

1.5

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

129

2.43

4.97

2.1

1.8

343.74

338.92

mu/l

0.04

107

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

225

1667

1.40

4.97

1.6

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

214

2.08

4.90

1.2

1.4

0.16

0.26

nmol/l

0.62

166

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

422

1.76

4.87

1.1

0.76

9.39

eliau/ml

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

475

1.71

4.86

2.3

3.5

21.48

51.31

mg/l

3.36

418

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

291

1.92

4.86

1.8

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

423

3455

1.29

4.83

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.65

4.82

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.09

4.79

1.1

133.40

526.50

ng/l

—

(3037121) Protein [Mass/volume] in Urine

523

1.67

4.79

3.8

3.4

249.69

439.76

mg/l

0.81

225

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.59

4.77

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

238

1794

1.37

4.74

1.7

1.39

1.40

0.06

207

1585

(3002256) Pathology report gross observation

312

2451

1.33

4.74

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

458

1.71

4.66

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

428

1.73

4.65

2.3

3.4

2.04

3.83

ratio

0.74

245

(3026389) Candida sp identified in Specimen by Organism specific culture

213

2.04

4.59

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

271

1.91

4.47

1.1

3.08

4.08

u/ml

0.26

128

(3044927) Protein electrophoresis panel - Urine

143

2.26

4.42

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

312

2475

1.31

4.41

6.4

5.5

1.73

2.56

ug/l

3.56

278

2202

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

415

1.71

4.31

1.2

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

446

1.69

4.29

1.9

2.4

0.00

g/l

-0.00

394

(3033658) Prothrombin time (PT) actual/Normal

496

4186

1.25

4.26

4.2

3.8

98.15

93.09

5.25

483

4104

(4146454) Self-monitoring of blood glucose

159

2.16

4.22

3.1

2.9

—

(3011985) Renin [Units/volume] in Plasma

234

1.95

4.22

1.7

1.4

61.47

52.29

mu/l

0.10

212

(3014271) Vancomycin [Susceptibility]

3.16

4.21

2.2

2.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

3.16

4.21

1.0

9.45

12.03

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

142

999

1.46

4.20

1.4

33.87

34.21

iu/l

0.04

124

879

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

322

1.79

4.15

1.1

0.65

1.90

u/ml

1.12

159

(40761536) Microorganisms panel - Urine sediment

175

1282

1.40

4.15

5.3

3.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

2.12

4.14

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

216

1639

1.36

4.13

2.4

2.3

0.22

0.21

g/l

2.14

205

1547

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

174

2.09

4.12

1.7

2.4

32.83

32.54

0.16

174

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.81

4.12

1.3

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.81

4.12

1.3

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.81

4.12

1.3

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

398

3297

1.26

3.99

2.4

3.0

2.44

2.45

mmol/l

1.24

360

3000

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

495

1.62

3.97

2.7

—

(3027945) Reticulocytes/Erythrocytes in Blood

218

1669

1.35

3.94

2.2

2.8

1.68

1.79

0.96

177

1492

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.96

3.79

1.3

—

(3042631) Mycobacterium sp identified in Specimen

201

1.96

3.78

2.7

2.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

237

1.88

3.75

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

267

1.82

3.71

1.3

1.4

—

82.22

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

418

1.65

3.71

1.9

2.4

0.00

g/l

-0.00

393

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

6.69

3.67

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

239

1.86

3.67

1.3

1.7

46.26

42.18

nmol/l

0.42

228

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

303

2453

1.28

3.66

3.4

2.7

5.20

3.64

e6/l

0.86

160

1113

(3025577) Chromium [Mass/volume] in Blood

2.70

3.66

2.0

2.3

2.35

2.77

ug/l

0.25

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

283

1.79

3.66

1.5

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

218

1.90

3.65

1.3

266.24

434.50

pmol/l

0.76

194

(3006184) Hemoglobin [Mass/volume] in Capillary blood

351

1.70

3.64

2.2

2.1

130.53

129.01

g/l

0.19

280

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

460

1.61

3.62

1.9

2.4

0.00

0.02

g/l

0.80

415

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

325

2658

1.27

3.61

3.3

2.6

1.14

1.20

e6/l

0.09

182

1324

(3016018) Differential panel - Cerebral spinal fluid

191

1.96

3.59

1.3

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.46

3.55

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.46

3.55

1.3

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.46

3.55

1.3

1.6

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.46

3.55

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.46

3.55

1.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.46

3.55

1.3

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

265

1.79

3.49

1.1

1.08

1.40

u/ml

0.16

103

(3010726) Horse dander IgE Ab [Units/volume] in Serum

258

1.80

3.48

1.1

0.69

1.57

u/ml

0.72

119

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

229

1.85

3.48

1.1

4.31

3.31

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

215

1.88

3.46

1.1

2.10

3.66

u/ml

0.47

(3014133) Dog dander IgE Ab [Units/volume] in Serum

238

1.83

3.40

1.1

2.00

1.92

u/ml

0.04

105

(3035637) Corticotropin [Mass/volume] in Plasma

188

1.93

3.39

1.4

1.5

48.15

30.01

ng/l

0.24

188

(3044290) Cell count panel - Cerebral spinal fluid

339

1.67

3.27

1.3

1.4

—

(3000012) Reticulocyte production index

184

1.92

3.25

1.7

2.4

1.03

0.90

0.55

115

(3011897) Casein IgE Ab [Units/volume] in Serum

4.75

3.24

1.0

1.1

0.15

0.05

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

3.55

3.19

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.81

3.09

1.8

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.51

3.04

1.6

1.9

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

5.85

3.02

1.0

1.2

3.22

4.89

nmol/l

—

(3008295) Osmolality of Serum or Plasma

168

1.92

3.00

1.4

273.88

279.76

mosm/kgh2o

0.83

139

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.55

2.96

1.1

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.55

2.96

1.1

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

664

0.58

2.95

1.1

0.46

0.64

ratio

—

101

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

191

1.85

2.93

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

199

1.82

2.90

1.1

1.0

0.05

0.08

u/ml

0.21

(3010144) Erythrocytes [#/volume] in Synovial fluid

122

2.06

2.87

1.4

24258.80

55291.75

e6/l

0.42

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.30

2.84

1.2

0.99

0.52

ratio

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

705

0.60

2.82

1.1

1.2

1.60

g/l

0.02

705

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.35

2.81

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.65

2.79

1.2

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.93

2.77

1.1

1.0

106.56

103.35

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

220

1773

1.27

2.77

1.5

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

8.35

2.75

1.2

0.02

0.04

u/ml

—

(3013637) Mi-2 Ab [Presence] in Serum

2.72

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.72

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.72

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.72

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

2.51

2.70

1.3

1.5

—

1.57

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.19

2.67

1.1

1.0

0.10

0.46

u/ml

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

273

1.66

2.66

1.2

1.1

6.50

15.38

au/ml

—

(1002224) Polysomnography panel

114

843

1.37

2.64

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

465

1.50

2.63

1.9

1296.33

5805.68

u/l

2.00

203

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

499

1.48

2.60

1.9

1.5

0.21

0.49

iu/ml

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

308

2597

1.22

2.60

1.7

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

215

1747

1.26

2.54

3.4

4.7

221.37

244.09

u/l

2.69

197

1668

(3044941) Cell count panel - Synovial fluid

269

1.65

2.54

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

308

1.61

2.54

5.8

2.3

—

(3020650) Glucose [Presence] in Urine

2.61

2.53

1.7

1.3

0.00

estimate

-0.00

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.51

2.53

1.5

1.4

38.38

116.62

umol/l

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

301

1.61

2.51

1.3

1.2

380.45

303.71

u/ml

0.33

180

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

349

1.56

2.50

1.4

1.5

77.61

656.71

e6/l

1.76

274

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.33

2.48

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

180

1.79

2.48

6.1

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

522

1.45

2.46

1.3

215.54

237.75

miu/ml

0.20

249

(1761482) Bacteria [#/volume] in Urine by Culture

351

0.48

2.45

4.3

3.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

123

1.96

2.45

1.1

20.90

8.92

iu/ml

—

(3012501) Base excess in Blood by calculation

264

1.64

2.45

3.2

3.4

3.63

2.82

mmol/l

0.86

181

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.68

2.45

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

335

1.57

2.45

1.2

1.3

14.62

13.84

u/l

0.14

267

(21494755) Public health laboratory ask at order entry panel

128

1657

0.76

2.44

1.3

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

346

1.55

2.36

1.5

1.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

4.13

2.36

1.4

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.51

2.36

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

284

1.60

2.32

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.23

2.27

1.1

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

684

1.38

2.27

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

185

1501

1.26

2.24

4.0

3.2

0.71

0.80

ug/l

0.85

121

989

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

5.57

2.21

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

121

1.91

2.21

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

158

1.78

2.18

1.4

1.2

113.89

113.35

pmol/l

0.02

158

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.30

2.15

1.2

1.1

0.02

u/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

347

1.51

2.13

1.4

19.26

39.42

e6/l

0.43

257

(44816559) Phosphatidylethanol [Mass/volume] in Blood

598

1.39

2.12

1.8

1.6

0.28

0.33

mg/l

0.36

258

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.06

2.11

1.1

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

117

904

1.31

2.09

1.9

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

147

1.78

2.02

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

148

1186

1.27

2.01

1.7

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

112

1.88

1.96

1.3

1.5

31.25

35.96

—

(3021901) Oxygen saturation in Capillary blood

273

1.55

1.96

2.5

3.0

91.97

90.42

2.13

267

(3052851) Hemolysis interference index of Serum or Plasma

429

1.44

1.95

1.8

3.3

2.18

2.15

index

0.01

231

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.99

1.95

1.1

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

233

1969

1.21

1.95

5.2

4.4

24.20

21.92

0.81

119

982

(3028626) Oxygen [Partial pressure] in Capillary blood

322

1.50

1.94

2.3

2.9

8.44

8.11

kpa

0.82

316

(3025549) Creatine [Moles/time] in 24 hour Urine

4.55

1.94

1.8

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

135

1.79

1.91

1.2

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

2.06

1.91

1.1

1.2

—

72.57

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

128

1.81

1.90

1.4

1.5

—

(3000330) Specific gravity of Urine by Test strip

741

1.33

1.90

2.4

3.1

1.01

1.02

ratio

2.96

668

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

139

0.36

1.88

1.0

1.4

338.80

339.34

u/l

—

134

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.19

1.88

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

252

1.56

1.87

1.5

1.8

—

18.23

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.65

1.86

1.0

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

351

1.47

1.84

3.7

2.9

57.46

58.34

0.22

351

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

1.70

1.82

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.92

1.80

1.9

2.3

102.89

103.72

0.03

(3016879) Cocaine [Presence] in Urine

420

1.42

1.79

3.9

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

161

1.69

1.78

1.4

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

109

1.84

1.77

1.0

1.6

—

24.71

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

438

1.41

1.77

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

154

0.39

1.75

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

117

1.80

1.74

1.4

1.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

117

1.80

1.74

1.6

3.8

68.10

112.77

nmol/l

2.72

117

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

499

1.38

1.74

2.9

3.1

1.47

1.49

mg/l

0.06

462

(4133840) Spirometry

2.51

1.74

1.3

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

214

1816

1.20

1.73

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

178

1.64

1.73

1.8

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

3.85

1.71

1.0

3.5

85.60

238.31

umol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

109

860

1.28

1.71

1.9

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

133

1077

1.25

1.69

2.6

2.2

3.45

7.72

ug/l

9.64

102

954

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

699

1.30

1.60

1.8

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

456

1.37

1.59

3.7

1.7

—

(1616796) Gas panel - Central venous blood

280

1.47

1.57

3.5

—

(3027008) Opiates [Presence] in Urine

457

1.37

1.57

3.7

1.7

—

(40768806) Pleura Pathology biopsy report

175

0.45

1.57

1.4

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.89

1.55

1.7

2.8

7.53

9.80

mmol/l

1.69

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

145

1.66

1.54

1.3

—

(3019150) Specific gravity of Urine by Refractometry

391

3515

1.14

1.54

4.3

3.6

1.02

kg/l

0.03

285

2312

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.93

1.54

1.1

1.52

1.12

u/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

100

1.81

1.53

3.1

1.5

102.25

93.00

ng/l

0.18

100

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

249

1.50

1.53

1.2

1.1

—

0.81

—

(3028300) Cannabinoids [Presence] in Urine

460

1.36

1.52

3.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

138

1.67

1.52

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

138

1.67

1.52

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

138

1.67

1.52

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

234

1.51

1.49

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

194

1.56

1.48

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

351

1.41

1.48

4.5

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

203

0.49

1.47

1.1

1.5

34.08

33.08

g/l

—

188

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

102

816

1.26

1.47

1.3

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

267

2345

1.16

1.46

1.5

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

319

1.42

1.45

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.88

1.44

1.1

1.0

1477.67

1499.53

miu/ml

0.03

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

413

1.37

1.44

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

460

0.67

1.43

2.5

3.7

21.86

29.99

u/ml

0.51

447

(3029396) Erythrocyte agglutination [Presence] in Blood

2.73

1.43

2.5

3.5

—

(1761868) Lipid panel - Serum or Plasma

758

7114

1.11

1.43

3.0

3.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

138

0.43

1.40

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

349

0.63

1.39

1.1

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

239

1.47

1.37

1.2

1.27

3.94

u/ml

1.30

(3012441) Differential panel - Pleural fluid

163

0.49

1.36

1.3

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

183

1.54

1.34

2.5

2.4

0.51

1.40

g/24h

1.74

111

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.04

1.33

1.1

—

(3037756) Immunofixation for Serum or Plasma

308

1.41

1.32

1.6

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

168

1.56

1.31

1.9

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

292

1.41

1.31

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

284

1.42

1.30

1.3

1.4

201.11

145.70

au/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

161

1.56

1.29

1.2

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1433

13933

1.12

1.28

20.3

17.7

13.52

13.58

1.10

1428

13731

(3003694) ABO and Rh group [Type] in Blood

512

4730

1.11

1.28

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

202

1.49

1.27

1.6

1.4

—

(40761535) Cells panel - Urine sediment

124

1033

1.21

1.27

3.8

3.2

—

(3042733) HLA Ab [Presence] in Serum

2.05

1.27

5.1

4.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.05

1.27

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.05

1.27

2.4

1.6

11.09

8.78

ug/l

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

115

951

1.22

1.26

6.4

7.0

24.86

24.91

mmol/l

0.05

115

946

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

219

1.47

1.26

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

320

1.38

1.26

1.3

1.4

—

24.71

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.75

1.25

1.4

—

(4015189) Microbial culture of sputum

2.40

1.24

8.2

2.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

192

1668

1.17

1.23

6.3

7.7

5.04

5.09

kpa

0.37

186

1617

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.00

1.23

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.05

1.22

2.1

1.1

16.79

17.99

umol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.17

1.21

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

470

1.31

1.21

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

117

1.63

1.18

1.1

1.2

18.03

14.65

u/ml

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

411

1.32

1.17

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

429

1.31

1.17

1.5

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.06

1.15

1.9

1.4

50.13

795.15

nmol/24h

—

(3023410) Appearance of Cerebral spinal fluid

166

1.51

1.15

1.3

1.6

—

(3019060) Gas panel - Arterial blood

780

1.23

1.14

4.2

5.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

309

1.37

1.14

1.5

1.4

—

(4281824) Cell count and differential, peritoneal fluid

259

0.61

1.14

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.69

1.13

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

114

0.44

1.12

1.0

1.2

25.40

10.57

u/l

—

104

(3035320) C reactive protein [Mass/volume] in Body fluid

111

1.63

1.12

4.1

2.4

17.85

28.30

mg/l

0.87

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.00

1.12

1.1

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

558

1.26

1.10

1.8

2.1

3.07

14.60

iu/l

0.61

235

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

496

1.28

1.09

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

269

1.38

1.09

1.3

61.13

57.93

mmol/l

0.18

215

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

205

1810

1.15

1.09

2.0

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.66

1.06

1.1

1.5

75.81

74.01

umol/l

0.10

(3047352) Trisomy 18 risk [Likelihood] in Fetus

253

0.63

1.05

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.80

1.04

1.2

—

(3017569) Oxygen content in Arterial blood

1.67

1.04

1.7

2.9

15.53

16.77

0.76

(3002079) Sodium [Moles/time] in 24 hour Urine

1.84

1.03

1.2

153.22

162.58

mmol/24h

0.14

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

256

1.37

1.01

1.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

334

1.32

1.00

2.5

2.4

46.50

83.66

ug/min

0.65

195

(3043238) Trisomy 21 risk [Likelihood] in Fetus

261

0.65

0.99

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

249

0.64

0.99

1.4

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

212

0.61

0.98

2.1

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

212

0.61

0.98

2.1

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

212

0.61

0.98

2.1

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

212

0.61

0.98

2.1

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.18

0.98

1.0

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.18

0.98

1.2

1.0

6.67

6.62

mg/g

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.67

0.98

1.4

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.97

0.0

2.5

—

6.77

—

(3034426) Prothrombin time (PT)

1.80

0.96

1.2

28.78

28.25

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

108

1.58

0.96

1.0

—

(4035726) Immunohistochemistry procedure

198

1762

1.14

0.96

1.3

1.4

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.69

0.95

1.2

1.1

8.38

11.23

mm/h

0.81

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

242

1.37

0.95

1.2

1.1

1.17

4.57

eliau/ml

—

121

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

185

0.59

0.94

1.5

1.6

71.53

55.31

ug/l

0.40

185

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.62

0.94

1.7

1.5

1.19

1.29

nmol/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

101

1.59

0.93

1.2

1.4

—

1278.33

—

(3003396) Base excess in Arterial blood by calculation

186

1654

1.14

0.91

6.5

7.7

1.05

0.95

mmol/l

0.15

153

1392

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

135

1548

0.86

0.91

1.7

3.43

3.53

mmol/l

0.55

103

1074

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.15

0.91

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

184

2061

0.88

0.89

2.0

3.26

3.35

ratio

0.52

150

1579

(3008037) Lactate [Moles/volume] in Venous blood

359

0.72

0.89

2.8

2.6

1.25

1.54

mmol/l

0.71

349

(3023419) Bacteria identified in Sputum by Culture

177

1.42

0.88

4.4

2.8

—

(3005033) Fetal Nuchal fold Thickness US

253

0.67

0.88

1.5

1.4

1.53

1.28

0.27

168

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.79

0.87

1.3

1.2

—

950.00

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.00

0.87

1.3

1.9

1.21

1.19

mmol/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

123

1068

1.16

0.85

2.7

2.9

92.68

190.02

ng/l

8.18

116

956

(3040151) Glucose [Moles/volume] in Capillary blood

153

1.44

0.85

1.6

5.7

7.38

7.54

mmol/l

0.10

131

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

317

1.30

0.85

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

145

1.45

0.85

3.0

4.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.74

0.82

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

526

1.22

0.82

1.6

1.7

423.93

324.19

mu/l

0.38

471

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

1.53

0.81

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

232

1.34

0.81

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

267

1.32

0.81

1.4

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

255

2334

1.11

0.79

1.8

2.1

28.99

29.40

0.53

250

2268

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.79

0.0

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

242

1.33

0.79

1.2

2.85

3.82

u/ml

0.47

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.56

0.78

1.6

2.6

1004.14

1362.63

u/ml

0.27

(3019977) pH of Arterial blood

185

1665

1.12

0.78

6.5

7.7

7.42

0.63

104

880

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.51

0.78

1.0

1.4

12.60

13.26

u/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

3.0

—

5.63

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.77

0.0

6.3

—

4.95

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

268

0.71

0.76

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.09

0.74

1.2

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

644

1.19

0.73

1.5

1.8

1.50

1.56

g/l

0.27

563

(3016650) Hepatitis A virus Ab [Presence] in Serum

281

1.29

0.73

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

148

1323

1.13

0.71

6.8

7.1

1.11

1.28

mmol/l

2.25

143

1299

(21491868) Cryoglobulin [Mass/volume] in Serum

1.58

0.71

1.0

1.2

—

0.21

g/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

126

1.43

0.70

1.4

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.51

0.69

1.1

1.09

1.05

ratio

—

(3027944) Amphetamines [Presence] in Urine

455

1.22

0.69

1.2

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

530

0.81

0.69

1.5

1.6

846.31

1034.76

mu/l

1.13

426

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.49

0.66

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.79

0.66

2.0

2.7

11.10

19.20

umol/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.62

0.65

1.2

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.48

0.64

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

581

1.18

0.62

2.1

2.0

1.18

2.47

ug/l

0.99

527

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.59

0.61

1.2

1.1

125.30

198.19

iu/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.60

0.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.00

0.60

0.0

6.9

—

10.09

—

(3002523) Influenza virus A Ag [Presence] in Specimen

326

1.23

0.60

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

354

1.22

0.59

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

299

0.77

0.59

1.4

1.12

1.10

ratio

0.06

182

(3003740) Influenza virus B Ag [Presence] in Specimen

327

1.23

0.58

1.1

—

(40768793) Breast Pathology biopsy report

623

1.16

0.58

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

219

0.73

0.57

1.6

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.48

0.57

2.0

3.0

0.64

0.61

mmol/l

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

138

1249

1.11

0.57

2.9

2.5

68.47

66.56

ml/min/173m2

0.24

524

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.46

0.56

4.9

4.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.54

0.55

2.5

2.3

—

(3006462) Nitrate [Presence] in Urine

1.48

0.53

3.2

3.0

—

(4268621) Lupus anticoagulant assay

169

1.31

0.53

2.4

2.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

214

1.27

0.52

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

232

1.25

0.52

1.1

125.25

118.01

0.63

213

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.62

0.52

1.2

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

478

0.83

0.51

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

333

1.21

0.51

7.5

5.3

16399.22

402.40

iu/ml

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.47

0.50

1.4

1.9

43.06

40.01

g/l

1.65

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

679

1.14

0.50

1.3

1.5

—

(4195642) Thrombophilia screening test

225

1.25

0.49

1.4

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

899

0.89

0.48

3.2

2.7

130.17

128.03

g/l

0.44

870

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

300

0.80

0.48

1.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

211

0.76

0.47

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

299

0.80

0.47

1.5

1.4

1.05

0.95

ratio

0.19

182

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

299

0.80

0.47

1.5

1.4

1.00

1.15

ratio

0.53

182

(44806420) Estimation of glomerular filtration rate

243

0.78

0.46

2.2

2.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

292

1.20

0.45

1.4

0.35

nmol/l

0.00

213

(3006653) Thiamine [Moles/volume] in Blood

1.40

0.44

1.8

1.2

137.83

130.34

nmol/l

0.35

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.37

0.44

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.37

0.44

1.1

1.3

153.59

158.37

pmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

313

1.19

0.42

1.3

2.1

0.84

0.82

nmol/l

0.04

259

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

131

1.30

0.42

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

369

1.17

0.42

2.1

3.9

33.64

1184.47

u/ml

0.98

337

(3036489) Thrombin time

605

0.87

0.42

1.7

1.8

23.58

20.83

0.51

533

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

149

1.28

0.42

1.9

2.8

—

(3045142) Bone marrow Pathology biopsy report

205

0.78

0.40

1.3

1.4

—

(3014891) Appearance of Pleural fluid

0.00

0.40

0.0

1.7

—

(40768446) Kidney Pathology biopsy report

1.31

0.39

2.1

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.34

0.39

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.43

0.39

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.43

0.39

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.43

0.39

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

148

0.74

0.38

1.1

1.4

6.58

6.26

mmol/l

0.19

143

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.37

0.38

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

344

0.84

0.37

1.5

1.4

—

(4211845) Urine protein measurement

1.33

0.37

3.2

2.9

—

(3005570) Glucose [Moles/volume] in Urine

161

1.24

0.37

1.5

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

116

1.30

0.37

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

199

1877

1.07

0.36

3.4

4.6

4.37

17.24

ug/l

2.48

163

1481

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

255

0.82

0.35

1.5

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.36

0.34

1.0

49.15

30.40

iu/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

109

1.29

0.33

1.1

1.4

1.32

1.13

promille

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

155

0.77

0.33

1.2

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.33

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.32

1.0

1.1

—

(4034850) Laboratory test

486

0.88

0.32

7.3

7.9

—

(3047181) Lactate [Moles/volume] in Blood

399

1.13

0.31

3.3

7.4

1.06

1.30

mmol/l

1.33

350

(3051611) Lipemic interference index of Serum or Plasma

165

1.21

0.31

1.9

3.0

16.22

12.61

index

—

106

(3022689) Creatine [Moles/volume] in Urine

1.30

0.30

2.0

1.4

9.90

7.33

mmol/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

177

1.19

0.27

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

168

1.19

0.27

1.5

—

(3002032) Base excess in Venous blood by calculation

134

1419

0.94

0.27

3.5

3.4

1.53

1.81

mmol/l

0.43

120

1240

(3047189) Immunofixation for 24 hour Urine

0.69

0.26

2.4

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

132

1.21

0.25

1.0

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

179

1709

1.05

0.25

2.1

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

142

1.20

0.24

3.8

3.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.19

0.24

3.4

5.7

—

68.64

—

(40768795) Lymph node Pathology biopsy report

231

0.86

0.22

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

1.19

0.21

1.2

145.36

65.22

mu/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

2.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

57.60

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

22.29

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

8.31

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

38.19

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.24

0.21

1.4

1.8

—

(4212803) Bone marrow aspirate examination

0.00

0.21

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.20

0.0

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.3

1.1

—

(3024932) HLA-DR beta [Type]

1.20

0.19

1.2

—

(3024471) HLA-A [Type]

1.18

0.19

1.2

1.0

—

(3012544) pH of Venous blood

141

1471

0.96

0.19

3.5

3.4

7.38

0.14

817

(21494434) Karyotype in Bone marrow

138

1.16

0.17

1.1

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

127

1219

1.04

0.16

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

178

1.12

0.15

1.7

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

267

1.09

0.13

1.0

1.3

12.77

24.53

u/l

1.67

229

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

967

0.96

0.12

9.9

9.0

1.29

1.21

0.39

958

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

363

0.94

0.11

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.09

0.09

1.6

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.06

0.09

1.6

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

744

0.97

0.08

3.3

2.4

1.43

1.16

0.55

737

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

338

0.95

0.08

1.3

1.4

—

(40768441) Liver Pathology biopsy report

156

1.09

0.08

2.3

1.3

—

(3024263) Appearance of Synovial fluid

1.06

0.08

2.0

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

143

1460

0.98

0.08

3.5

3.3

5.81

5.78

kpa

0.15

138

1413

(3016228) CD19 cells/cells in Blood

0.86

0.07

1.7

2.0

6.00

7.84

—

(40765096) Chromosome analysis panel by Banding

0.83

0.07

1.0

1.1

—

(3017704) Immunofixation for Urine

0.83

0.07

1.2

1.8

—

(21494814) CD8 cells/Lymphocytes in Specimen

0.82

0.07

1.7

1.9

29.50

29.25

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.04

0.07

1.0

1.1

—

3.27

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

186

1.08

0.07

7.9

5.8

79.79

60.68

u/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.07

0.07

1.1

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

739

0.97

0.06

3.3

2.4

0.56

0.63

1.17

733

(3004451) EKG impression Narrative

1.11

0.05

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

643

1.03

0.05

3.2

3.9

22.42

808.24

u/ml

2.08

547

(3051387) C reactive protein [Mass/volume] in Capillary blood

356

1.04

0.05

4.8

3.5

35.84

24.97

mg/l

0.61

243

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

110

1.09

0.05

1.1

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

110

1.09

0.05

1.4

1.9

—

(40768800) Prostate Pathology biopsy report

169

1.07

0.05

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

928

0.98

0.05

10.4

9.3

0.60

0.63

0.33

921

(3000991) Gas panel - Venous blood

131

1290

1.02

0.05

8.4

8.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

289

1.04

0.04

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

289

1.04

0.04

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

107

1081

0.99

0.02

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

452

1.02

0.01

5.3

3.0

0.38

0.37

iu/ml

0.05

250

(3025130) Human papilloma virus identified in Specimen

344

1.02

0.00

2.0

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

175

0.97

0.00

1.2

1.7

2.24

4.60

ug/l

0.69

142

(44813793) Dust mix specific IgE antibody measurement

109

1.01

0.00

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

512

1.00

0.00

1.6

1.9

96.91

92.27

0.62

491

(21494890) Protein electrophoresis panel - 24 hour Urine

142

0.99

0.00

2.0

2.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

202

0.99

0.00

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

107

1.03

0.00

1.9

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

127

1.02

0.00

11.2

7.3

2150.20

58.26

ug/l

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.4

—

0.05

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

328.44

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(4198724) Urine methamphetamine measurement

1.02

0.00

1.2

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.96

-0.00

1.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

4.0

—

115.60

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.50

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.4

—

372.20

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

8.7

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

3.8

—

2.34

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.55

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

62.04

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_GLUTEALTEND and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_GLUTEALTEND	0.849 [0.71, 1.02]	0.083
Birth year	0.998 [0.99, 1.01]	0.645

During the follow-up period (1.1.1998 — 31.12.2019), 203 out of 3143 females with M13_GLUTEALTEND died.

Males

Parameter	HR [95% CI]	p-value
M13_GLUTEALTEND	0.776 [0.6, 1.01]	0.058
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 78 out of 992 males with M13_GLUTEALTEND died.

Mortality risk

Mortality risk for people of age

years, who have M13_GLUTEALTEND.

N-year risk	Females	Males
1	0.103%	0.125%
5	0.46%	0.885%
10	1.432%	2.112%
15	2.617%	3.874%
20	4.495%	6.693%

Relationships between endpoints

↥

Index endpoint: M13_GLUTEALTEND – Gluteal tendinitis

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Gluteal tendinitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints